Navigation Links
New Data Show Efficacy of Zebinix(TM) in the Treatment of Epilepsy
Date:9/24/2008

nel blocker that has been designed to reduce the frequency of partial-onset seizures when used in combination with other anti-epileptic drugs.

This treatment has the potential to offer a new therapeutic option for patients who continue to suffer partial seizures despite receiving other anti-epileptic agents, with the potential for additional benefits in terms of improvements in quality of life and depressive symptoms.(2,3,4,5,6,7)

About BIAL

Founded in 1924, BIAL is an international pharmaceuticals group with products available in nearly 30 countries over four continents. BIAL group is the largest Portuguese pharmaceutical company and is based in S. Mamede do Coronado, Portugal.

BIAL is strongly committed to therapeutic innovation on research and development every year. This commitment has been recognised in the group's recent integration into the EFPIA (European Federation of Pharmaceutical Industries and Associations), which is dedicated to encouraging research and the development of new therapeutic options.

Key research areas for BIAL are the central nervous system, the cardiovascular system and allergology. BIAL's dedication to research is further demonstrated by the research grants and awards offered by the BIAL Foundation.

Further information about BIAL can be found at http://www.bial.com

References

(1). Zebinix(TM) is one of the proposed EU trade names for Eslicarbazepine acetate

(2). Elger C, Halasz P, Maia J et al. Efficacy and safety of eslicarbazepine acetate as add-on treatment in adults with refractory partial-onset seizures: BIA-2093-301 Study. Abstract and oral communication, presented at the 8th European Congress on Epileptology, Berlin, Germany, 21-25 September 2008.

(3). Hufnagel A, Ben-Menachem E, Gabbai A et al. Efficacy and safety of eslicarbazepine acetate as add-on treatment in adults with refractory partial-onset seizures: BIA
'/>"/>

SOURCE BIAL
Copyright©2008 PR Newswire.
All rights reserved

1

GOOD

Page: 1 2 3 4 5 6

Related medicine technology :

1. MicroRNA First Disclosed by Rosetta Genomics may Increase Efficacy of Imatinib (Gleevec(R)(1)) in Glioblastoma
2. Continuous Treatment With Abbotts HUMIRA(R) Achieves Superior Long-Term Efficacy for Psoriasis Patients Compared to Interrupting Treatment
3. Interface Biologics Anti-Thrombic Additives Show Equivalent Efficacy to Commercial Heparinized Coatings
4. NicOx Announces Second Naproxcinod Pivotal Phase 3 Study (302) Meets Efficacy Primary Endpoints and Supports Non-Detrimental Blood Pressure Effect
5. Alpharma Announces Positive Results From Pivotal Phase III Efficacy Trial on ALO-01 (EMBEDA(TM)) (morphine sulfate extended-release with sequestered naltrexone hydrochloride) Capsules at the American Academy of Pain Management Annual Clinical Meeting
6. Biosensors DES Demonstrates Equivalent Safety and Efficacy to Industry Leading DES in First Real World, All Comers Clinical Study
7. Isolagen, Inc. Reports Positive Top-line Results from Pivotal Phase III Studies of Isolagen Therapy(TM) in Wrinkles: Studies Meet All Primary Efficacy Endpoints and are Statistically Significant
8. Medivation Presents Positive New Data on Dimebons Long-Term Efficacy and Novel Mechanism of Action at the International Conference on Alzheimers Disease
9. Jennerex Publishes Clinical Trial Data With Lead Product JX-594 Demonstrating Efficacy Against Liver Cancer and Associated Hepatitis B Virus
10. Isolagen Completes Pivotal Efficacy Portion of Phase III Studies of Isolagen Therapy(TM) for Wrinkles
11. Eisai Provides Preliminary Efficacy Update On EORTC Phase III Trial of Dacogen(R) Versus Supportive Care in Patients With Myelodysplastic Syndromes

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/9/2009)...swire/ -- Access MediQuip, LLC, the nation,s first...dical device management solutions to the healthcar...its corporate headquarters to Lake Mary, Florida. ...growth, includes a major expansion of the Primera ...uary 2010 and relocation and expansion of the Hous...
(Date:11/9/2009)...tCall/ -- ISTA Pharmaceuticals, Inc. (Nasdaq: IST...ompany,s Bepreve(TM) (bepotastine besilate ophthal...e results were presented in poster sessions at the...lergy, Asthma & Immunology (ACAAI) in Miami Be...Treatment of Ocular Itching with Bepotastine Besil...
(Date:11/9/2009)...wswire/ -- Thomson Reuters today announced the n...eading clinical surveillance solution that enables...me and respond immediately to improve clinical qua...s upgrade is available to current CareFocus custom...ontains several powerful enhancements that improve...
Breaking Medicine Technology:Access MediQuip Moves Company Headquarters to Lake Mary, Florida 2ISTA Pharmaceuticals Highlights Bepreve(TM) Clinical Data at the 2009 Annual Meeting of the American College of Allergy, Asthma & Immunology (ACAAI) 2ISTA Pharmaceuticals Highlights Bepreve(TM) Clinical Data at the 2009 Annual Meeting of the American College of Allergy, Asthma & Immunology (ACAAI) 3Thomson Reuters Clinical Surveillance Solution Offers Powerful New Functionality to Improve Clinical Quality and Reduce Costs 2Thomson Reuters Clinical Surveillance Solution Offers Powerful New Functionality to Improve Clinical Quality and Reduce Costs 3Proteins in gel 8982 1PharmaVentures Assists Helsinn in the Successful Sale of Helsinn Chemicals Ireland to the Medinco C F M Group 12767 1PharmaVentures Assists Helsinn in the Successful Sale of Helsinn Chemicals Ireland to the Medinco C F M Group 12767 2PHT Names VP to Lead Sales of A Claim Payment Solution for Doctors Hospitals 49924 1PHT Names VP to Lead Sales of A Claim Payment Solution for Doctors Hospitals 49924 2
...stent may hold clinical edge over Taxus stent at t..., March 31 Early results of the SPIRIT II study,s...Taxus stent in six-month,findings on angiography a...ow, a new analysis shows that after two years, the... may continue to hold a clinical edge over,its pac...
...any,s TAXUS(R) and PROMUS(TM) Stents demonstrate p...mes, NATICK, Mass. and CHICAGO, March 31 Boston,...d positive two-year results,from Abbott,s prospect...ty,SPIRIT II Trial comparing the safety and effica...ting Coronary Stent and Boston Scientific,s,worldw...
Other Medicine Technology:SPIRIT II Explores Long-Term Performance of XIENCE V Stent 2SPIRIT II Explores Long-Term Performance of XIENCE V Stent 3Spirit II Results Support Strength of Boston Scientific's Two Drug-Eluting Stent Platforms 2Spirit II Results Support Strength of Boston Scientific's Two Drug-Eluting Stent Platforms 3Spirit II Results Support Strength of Boston Scientific's Two Drug-Eluting Stent Platforms 4
(Date:11/9/2009)... , Fast food chains are o...obesity. A recent poll by Fitness.com.au however f...shoulder the responsibility. , ...ast food chains, and video games were behind Austr...nd Dad are more than just innocent bystanders. A r...
(Date:11/9/2009)... , New study highlights p...health , Rosemont, IL (Vo...ncrease and bone health decreases. Recent research...lcium supplements to help prevent these issues. Ho...ber issue of Sports Health: A Multidisciplinary A...
(Date:11/9/2009)... , LEBANON, Tenn., Nov. 9 Hea...oday announced it will host their inaugural Hospit...3-15, 2010 at the Marriott Renaissance Hotel in Na...pecting more than 100 hospital operating room dire...als and health systems in the country. Some of the...
(Date:11/9/2009)... , DETROIT, Nov. 9 ...armanos Cancer Center has been selected the most p...higan, according to a survey by the National Resea...m.com/cgi-bin/prnh/20071106/KARMANOSLOGO ) ,, ...uestionnaire between September 2008 and August 200...
(Date:11/9/2009)... Study didn,t answer question of why this is so, ...News) -- After a lumpectomy, women with very dense...n the affected breast, a new study shows. , Bre...sed risk of developing breast cancer, and experts ... associated with an increased risk of cancer recur...
Breaking Medicine News(10 mins):Health News:Fitness.com.au Poll Finds 80% Blame Parents For Our Overweight Kids 2Health News:High Impact Sports Participation May Improve Bone Mineral Density in Mature Athletes 2Health News:Health Connect Partners Hosts Hospital O.R. & Surgery Center Conference 2Health News:Karmanos Cancer Center Most Preferred Hospital for Cancer Care in Southeast Michigan, Third Consecutive Year 2Health News:Dense Breasts Raise Risk of Cancer Recurrence 2Health News:Dense Breasts Raise Risk of Cancer Recurrence 3
...thorities have broken off talks with striking doct...inister's office for about 20 days to demand highe..."There will be no more discussions with the unions...ent had offered pay increases in 2008 but the stri...
...dy has shown that taking selenium supplements may,... The study, published in the Annals of Interna... that selenium supplements cause type 2 diabetes, ...nium is a naturally occurring trace mineral presen...
...tle life fraught with danger, for pre-mature babie...-preemies , as they weigh less than 1000 grams, th... tiny babies. Doctors who care for these low...le. Though advances in medical technology have i...
...irst time, researchers have shown that plant growt...nal light . Using time-lapse photography, ...eagues from the University of California, Davis, a...ming of that growth spurt is controlled by both th...
...ver cases in affluent Singapore have surged to the...levels, official figures showed Tuesday . ...ected last week, the second week in a row that the...nistry and the National Environment Agency said in...
...r to be published in the July issue of Cancer Biol...eports finding a significant link between genetic ...8 and the risk of colorectal cancer. A 10-yea...n in the search for the genes that make a person m...
Other Medicine News:Health News:Selenium Supplements may Increase Type 2 Diabetes Risk 2Health News:Medical Science Strides-No Guarantee For Pre-Mature Babies 2Health News:Advancement in Gene Associated With Colon Cancer 2Health News:Advancement in Gene Associated With Colon Cancer 3Health News:Advancement in Gene Associated With Colon Cancer 4
...ational reference laboratory and a worldwide leade...t. ARUP offers an extensive test menu of highly co...tomic pathology. Owned by the University of Utah, ...of the nation's university teaching hospitals and ...
...ational reference laboratory and a worldwide leade...t. ARUP offers an extensive test menu of highly co...tomic pathology. Owned by the University of Utah, ...of the nation's university teaching hospitals and ...
...ational reference laboratory and a worldwide leade...t. ARUP offers an extensive test menu of highly co...tomic pathology. Owned by the University of Utah, ...of the nation's university teaching hospitals and ...
...ational reference laboratory and a worldwide leade...t. ARUP offers an extensive test menu of highly co...tomic pathology. Owned by the University of Utah, ...of the nation's university teaching hospitals and ...
Medicine Products: